Guest Contributor Karthik Achari, founder of PepMD, explores why traditional provider verification processes are struggling to keep pace with the rapid expansion of telehealth and decentralized care models. Today’s patients will probably check online ratings…

As regulators accelerate the phase-out of animal testing, New Approach Methodologies are moving from policy to practice — and reshaping which neuroscience instruments, readouts, and workflows matter most.

SDi analysts cover the key findings from the 2026 Global Assessment Report — market sizing, five-year forecasts, vendor rankings, and competitive trends across 80+ instrument technologies. Free. On demand. 30 minutes.

Pathology has long been defined by three familiar images: a microscope, a glass slide, and a specialist interpreting what they see. That model still exists, but in 2026 and beyond, it’s no longer where the…

Oncology Cell & Gene Therapy: Market Snapshot CAR-T has long been the dominant force in cell and gene therapy, but understanding just how dominant, and what that means for the rest of the oncology CGT…